TimesSquare Capital Management LLC Buys Shares of 313,549 Addus HomeCare Corporation $ADUS

TimesSquare Capital Management LLC bought a new stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 313,549 shares of the company’s stock, valued at approximately $31,502,000. TimesSquare Capital Management LLC owned about 1.68% of Addus HomeCare at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Capital Research Global Investors grew its stake in Addus HomeCare by 22.3% during the 4th quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock worth $157,837,000 after buying an additional 268,192 shares during the last quarter. Vanguard Group Inc. lifted its stake in Addus HomeCare by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock valued at $140,531,000 after buying an additional 10,501 shares during the last quarter. Wasatch Advisors LP lifted its stake in Addus HomeCare by 0.8% in the third quarter. Wasatch Advisors LP now owns 936,243 shares of the company’s stock valued at $110,467,000 after buying an additional 7,089 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Addus HomeCare by 11.8% during the first quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company’s stock valued at $69,689,000 after acquiring an additional 78,415 shares during the period. Finally, State Street Corp boosted its holdings in shares of Addus HomeCare by 0.9% during the fourth quarter. State Street Corp now owns 702,229 shares of the company’s stock valued at $75,412,000 after acquiring an additional 6,561 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on ADUS. Royal Bank Of Canada increased their price objective on shares of Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Weiss Ratings raised shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Citigroup restated a “market outperform” rating on shares of Addus HomeCare in a research report on Friday, July 24th. Barclays raised their price target on shares of Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research note on Wednesday, July 8th. Finally, Citizens Jmp reiterated a “market outperform” rating and set a $142.00 price objective on shares of Addus HomeCare in a research report on Monday, May 18th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $130.88.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS opened at $114.90 on Tuesday. The stock has a market cap of $2.15 billion, a P/E ratio of 20.16, a P/E/G ratio of 1.56 and a beta of 0.87. The firm’s 50-day simple moving average is $107.32 and its 200 day simple moving average is $102.01. Addus HomeCare Corporation has a fifty-two week low of $87.95 and a fifty-two week high of $124.43. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.05.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, August 3rd. The company reported $1.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.70 by $0.03. The firm had revenue of $377.41 million during the quarter, compared to analyst estimates of $376.24 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. Addus HomeCare’s revenue was up 8.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.49 EPS. Equities analysts expect that Addus HomeCare Corporation will post 6.29 EPS for the current year.

Insider Buying and Selling at Addus HomeCare

In other news, insider Heather Brianne Dixon sold 288 shares of the stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the transaction, the insider directly owned 44,371 shares in the company, valued at $4,160,668.67. This trade represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 4.10% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.